Jienny Lee

Title: Jienny Lee: Innovator in Canine Parvovirus Research

Introduction

Jienny Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines and diagnostic tools for canine parvovirus.

Latest Patents

Jienny Lee holds a patent for a recombinant canine parvovirus 2a VP2 and 2b VP2 antigen protein. The patent describes a recombinant expression vector that includes a gene encoding the canine parvovirus 2a VP2 or 2b VP2 protein. This invention also encompasses a recombinant plant transformed with the vector, a vaccine composition against canine parvovirus, and a diagnostic composition for the virus. The recombinant plant allows for the rapid and efficient production of the antigen protein, ensuring safety by eliminating the risk of contamination from live virus handling. This innovation facilitates quick diagnosis of canine parvovirus infection from large sample sizes.

Career Highlights

Throughout his career, Jienny Lee has worked with reputable organizations, including the Animal and Plant Quarantine Agency of the Republic of Korea and Bioapplications Inc. His work has focused on enhancing the safety and efficacy of veterinary vaccines and diagnostics.

Collaborations

Jienny Lee has collaborated with notable colleagues such as In-Ohk Ouh and Jae-Young Song, contributing to advancements in his field.

Conclusion

Jienny Lee's innovative work in the development of canine parvovirus diagnostics and vaccines highlights his commitment to improving animal health. His contributions are significant in the veterinary field, showcasing the importance of research and innovation in combating infectious diseases.